Research location
Alphen aan den Rijn
Netherlands
Advertisement
Research activity in Alphen aan den Rijn
NetherlandsCureCurrent currently publishes aggregate city-level research activity for this location: 12 trials and 12 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Alphen aan den Rijn
12 linked trials · page 1 of 1SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes TrialNCT04972721 · 2023-09-01 · 1 site observation
COMPLETED
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical PracticeNCT04601740 · 2020-11-17 · 1 site observation
COMPLETED
An International Survey on Hypoglycaemia Among Insulin-treated Patients With DiabetesNCT01696266 · 2012-09-05 · 1 site observation
COMPLETED
Diabetes Attitudes Wishes and NeedsNCT01507116 · 2012-03-01 · 1 site observation
COMPLETED
Observational Study on Levemir® in Obese Diabetic PatientsNCT00849342 · 2008-12-01 · 1 site observation
COMPLETED
European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT00722267 · 2008-07-01 · 1 site observation
COMPLETED
INVISION - An Observational Study to Explore Effectiveness, Tolerability and Safety of Paliperidone ER in Patients With SchizophreniaNCT00697658 · 2008-03-01 · 1 site observation
COMPLETED
Combination of Olmesartan and Hydrochlorothiazide in Essential HypertensionNCT00430950 · 2007-02-01 · 1 site observation
COMPLETED
The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment SatisfactionNCT01542476 · 2006-08-01 · 1 site observation
COMPLETED
Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the NetherlandsNCT01536626 · 2006-06-09 · 1 site observation
COMPLETED
DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European GuidelinesNCT00233649 · 2004-05-01 · 1 site observation
COMPLETED
Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 DiabetesNCT01697618 · 1997-04-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.